|
1
|
Ellis EL and Mann DA: Clinical evidence
for the regression of liver fibrosis. J Hepatol. 56:1171–1180.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee YA, Wallace MC and Friedman SL:
Pathobiology of liver fibrosis: A translational success story. Gut.
64:830–841. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Carson JP, Ramm GA, Robinson MW, McManus
DP and Gobert GN: Schistosome-induced fibrotic disease: The role of
hepatic stellate cells. Trends Parasitol. 34:524–540. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Higashi T, Friedman SL and Hoshida Y:
Hepatic stellate cells as key target in liver fibrosis. Adv Drug
Deliv Rev. 121:27–42. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Khomich O, Ivanov AV and Bartosch B:
Metabolic hallmarks of hepatic stellate cells in liver fibrosis.
Cells. 9:92019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wallace MC, Friedman SL and Mann DA:
Emerging and disease-specific mechanisms of hepatic stellate cell
activation. Semin Liver Dis. 35:107–118. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dewidar B, Meyer C, Dooley S and
Meindl-Beinker AN: TGF-β in hepatic stellate cell activation and
liver fibrogenesis-updated 2019. Cells. 8:82019. View Article : Google Scholar
|
|
8
|
Eskelinen EL, Illert AL, Tanaka Y,
Schwarzmann G, Blanz J, Von Figura K and Saftig P: Role of LAMP-2
in lysosome biogenesis and autophagy. Mol Biol Cell. 13:3355–3368.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ravikumar B, Sarkar S, Davies JE, Futter
M, Garcia-Arencibia M, Green-Thompson ZW, Jimenez-Sanchez M,
Korolchuk VI, Lichtenberg M, Luo S, et al: Regulation of mammalian
autophagy in physiology and pathophysiology. Physiol Rev.
90:1383–1435. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mizushima N, Levine B, Cuervo AM and
Klionsky DJ: Autophagy fights disease through cellular
self-digestion. Nature. 451:1069–1075. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ke PY: Diverse functions of autophagy in
liver physiology and liver diseases. Int J Mol Sci. 20:202019.
View Article : Google Scholar
|
|
12
|
Qian H, Chao X, Williams J, Fulte S, Li T,
Yang L and Ding WX: Autophagy in liver diseases: A review. Mol
Aspects Med. Jun 10–2021.(Epub ahead of print). doi:
10.1016/j.mam.2021.100973. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu N, Chen L, Yan D, Zhou M, Shao C, Lu Y,
Yao Q, Sun H and Fu Y: Trehalose attenuates TGF-β1-induced fibrosis
of hSCFs by activating autophagy. Mol Cell Biochem. 470:175–188.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang X, He Y, Mackowiak B and Gao B:
MicroRNAs as regulators, biomarkers and therapeutic targets in
liver diseases. Gut. 70:784–795. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mohr AM and Mott JL: Overview of microRNA
biology. Semin Liver Dis. 35:3–11. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Khan MI, Hamid A, Adhami VM, Lall RK and
Mukhtar H: Role of epithelial mesenchymal transition in prostate
tumorigenesis. Curr Pharm Des. 21:1240–1248. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang PS, Chang CC, Wang CS and Lin KH:
Functional roles of non-coding RNAs regulated by thyroid hormones
in liver cancer. Biomed sJ. 44:272–284. 2021.PubMed/NCBI
|
|
18
|
Jiang Y, He J, Li Y, Guo Y and Tao H: The
diagnostic value of MicroRNAs as a biomarker for hepatocellular
carcinoma: A meta-analysis. BioMed Res Int. 2019:51790482019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Roderburg C, Urban GW, Bettermann K, Vucur
M, Zimmermann H, Schmidt S, Janssen J, Koppe C, Knolle P, Castoldi
M, et al: Micro-RNA profiling reveals a role for miR-29 in human
and murine liver fibrosis. Hepatology. 53:209–218. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pineau P, Volinia S, McJunkin K, Marchio
A, Battiston C, Terris B, Mazzaferro V, Lowe SW, Croce CM and
Dejean A: miR-221 overexpression contributes to liver
tumorigenesis. Proc Natl Acad Sci USA. 107:264–269. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
He XX, Guo AY, Xu CR, Chang Y, Xiang GY,
Gong J, Dan ZL, Tian DA, Liao JZ and Lin JS: Bioinformatics
analysis identifies miR-221 as a core regulator in hepatocellular
carcinoma and its silencing suppresses tumor properties. Oncol Rep.
32:1200–1210. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kannan M, Jayamohan S, Moorthy RK,
Chabattula SC, Ganeshan M and Arockiam AJ: AEG-1/miR-221 axis
cooperatively regulates the progression of hepatocellular carcinoma
by targeting PTEN/PI3K/AKT signaling pathway. Int J Mol Sci.
20:202019. View Article : Google Scholar
|
|
23
|
Fu Y, Liu M, Li F, Qian L, Zhang P, Lv F,
Cheng W and Hou R: MiR-221 promotes hepatocellular carcinoma cells
migration via targeting PHF2. BioMed Res Int. 2019:43714052019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Baglieri J, Brenner DA and Kisseleva T:
The role of fibrosis and liver-associated fibroblasts in the
pathogenesis of hepatocellular carcinoma. Int J Mol Sci. 20:202019.
View Article : Google Scholar
|
|
25
|
Ebrahimkhani MR, Oakley F, Murphy LB, Mann
J, Moles A, Perugorria MJ, Ellis E, Lakey AF, Burt AD, Douglass A,
et al: Stimulating healthy tissue regeneration by targeting the
5-HT-B receptor in chronic liver disease. Nat Med. 17:1668–1673.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang R, Gao N, Chang Q, Meng X and Wang W:
The role of IDO, IL-10, and TGF-β in the HCV-associated chronic
hepatitis, liver cirrhosis, and hepatocellular carcinoma. J Med
Virol. 91:265–271. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jones-Bolin S: Guidelines for the care and
use of laboratory animals in biomedical research. Curr Protoc
Pharmacol. Dec 1–2012.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hyun J, Wang S, Kim J, Rao KM, Park SY,
Chung I, Ha CS, Kim SW, Yun YH and Jung Y: MicroRNA-378 limits
activation of hepatic stellate cells and liver fibrosis by
suppressing Gli3 expression. Nat Commun. 7:109932016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ding ZY, Jin GN, Liang HF, Wang W, Chen
WX, Datta PK, Zhang MZ, Zhang B and Chen XP: Transforming growth
factor β induces expression of connective tissue growth factor in
hepatic progenitor cells through Smad independent signaling. Cell
Signal. 25:1981–1992. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shu Y, Liu X, Huang H, Wen Q and Shu J:
Research progress of natural compounds in anti-liver fibrosis by
affecting autophagy of hepatic stellate cells. Mol Biol Rep.
48:1915–1924. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Song B, Wang Y, Xi Y, Kudo K, Bruheim S,
Botchkina GI, Gavin E, Wan Y, Formentini A, Kornmann M, et al:
Mechanism of chemoresistance mediated by miR-140 in human
osteosarcoma and colon cancer cells. Oncogene. 28:4065–4074. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jiang X, Jiang L, Shan A, Su Y, Cheng Y,
Song D, Ji H, Ning G, Wang W and Cao Y: Targeting hepatic
miR-221/222 for therapeutic intervention of nonalcoholic
steatohepatitis in mice. EBioMedicine. 37:307–321. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xu J, Su Y, Xu A, Fan F, Mu S, Chen L, Chu
Z, Zhang B, Huang H, Zhang J, et al: miR-221/222-mediated
inhibition of autophagy promotes dexamethasone resistance in
multiple myeloma. Mol Ther. 27:559–570. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li F, Long TY, Bi SS, Sheikh SA and Zhang
CL: circPAN3 exerts a profibrotic role via sponging miR-221 through
FoxO3/ATG7-activated autophagy in a rat model of myocardial
infarction. Life Sci. 257:1180152020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu N, Feng J, Lu X, Yao Z, Liu Q, Lv Y,
Han Y, Deng J and Zhou Y: Isorhamnetin inhibits liver fibrosis by
reducing autophagy and inhibiting extracellular matrix formation
via the TGF-β1/Smad3 and TGF-β1/p38 MAPK Pathways. Mediators
Inflamm. 2019:61750912019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Eskelinen EL: Roles of LAMP-1 and LAMP-2
in lysosome biogenesis and autophagy. Mol Aspects Med. 27:495–502.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gozuacik D, Akkoc Y, Ozturk DG and Kocak
M: Autophagy-regulating microRNAs and cancer. Front Oncol.
7:652017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Babuta M, Furi I, Bala S, Bukong TN, Lowe
P, Catalano D, Calenda C, Kodys K and Szabo G: Dysregulated
autophagy and lysosome function are linked to exosome production by
Micro-RNA 155 in alcoholic liver disease. Hepatology. 70:2123–2141.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lodder J, Denaës T, Chobert MN, Wan J,
El-Benna J, Pawlotsky JM, Lotersztajn S and Teixeira-Clerc F:
Macrophage autophagy protects against liver fibrosis in mice.
Autophagy. 11:1280–1292. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Fabregat I and Caballero-Díaz D:
Transforming growth factor-β-induced cell plasticity in liver
fibrosis and hepatocarcinogenesis. Front Oncol. 8:3572018.
View Article : Google Scholar : PubMed/NCBI
|
